* Grail Inc GRAL.OQ GRAL.O is expected to report
resultson
February 20 for the period ending March 31 2024
*
* LSEG's mean analyst estimate for Grail Inc is for a loss
of
$7.05 per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "Hold".
* Wall Street's median 12-month price target for Grail Inc
is
$16.00, below its last closing price of $55.02.
This summary was machine generated February 18 at 21:37 GMT.
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)